Trial Profile
A proof of concept study of AQU-005 in patients with neuropathic pain
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs AQU 005 (Primary)
- Indications Neuropathic pain
- Focus Proof of concept; Therapeutic Use
- 30 Jun 2016 New trial record
- 28 Jun 2016 According to a NeuroMax media release, the company is planning to start this study in the fourth quarter of 2016.